Paclitaxel biological synthesis promotes the innovation of anti‐cancer drugs

Paclitaxel biological synthesis promotes the innovation of anti‐cancer drugs

Saved in:

Bibliographic Details
Main Authors:	Xiaolin Zhang, Gang Liu, Jianbin Yan
Format:	Article
Language:	English
Published:	Wiley 2025-02-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.70230
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer
by: Shuning Chen, et al.
Published: (2025-04-01)

Efficacy of albumin-bound paclitaxel versus paclitaxel in esophageal cancer: a systematic review and meta-analysis
by: Jiayang Song, et al.
Published: (2025-08-01)

The pharmacology of paclitaxel in cancer therapy
by: Jiang Xinmei
Published: (2025-01-01)

History of paclitaxel and oral paclitaxel – Clinical data and future
by: Ganesh Divekar, et al.
Published: (2020-01-01)

Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
by: Shao-Jing Wang, et al.
Published: (2025-03-01)

Synthesis biological evaluation and molecular docking of isatin hybrids as anti-cancer and anti-microbial agents
by: Mohammad Altamimi, et al.
Published: (2024-12-01)

Synthesis and biological evaluation of esterified anti-inflammatory drugs with ethylene glycol linkers: cytotoxicity, anti-inflammatory and antioxidant properties
by: Pascaline M. Deussom, et al.
Published: (2025-05-01)

Evaluation of the parameters affecting the loading of anticancer drug Paclitaxel on coated gold nanoparticles for breast cancer treatment
by: Afrooz kharazmi, et al.
Published: (2023-05-01)

Cetuximab and Paclitaxel Drug Response in Head and Neck Tumor Stem Cells
by: Vilson Serafim Júnior, et al.
Published: (2025-02-01)

Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion
by: Rebecca S. Y. Wong
Published: (2019-01-01)

Alleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory Drugs
by: Anthony M. Kyriakopoulos, et al.
Published: (2017-01-01)

“Nano-Paclitaxel” Unlocking Potential and Redefining Cancer Chemotherapy
by: Anuja Muley, et al.
Published: (2025-06-01)

Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis
by: Xingzhen Cheng, et al.
Published: (2022-01-01)

Drug delivery process simulation-Quantifying the conformation dynamics of paclitaxel and cremophor EL.
by: Mafiz Uddin, et al.
Published: (2025-01-01)

Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery
by: Ramesh Ganpisetti, et al.
Published: (2025-05-01)

Synthesis and Characterization of Poly(Lactic-Co-Glycolic Acid)–Paclitaxel (PLGA-PTX) Nanoparticles Evaluated in Ovarian Cancer Models
by: Sylwia A. Dragulska, et al.
Published: (2025-05-01)

Synthesis and biological evaluation of new tri-heterocyclic derivatives as anti-colorectal cancer agents
by: Benjamin Victoir, et al.
Published: (2025-01-01)

Paclitaxel/Luteolin Coloaded Dual‐Functional Liposomes for Esophageal Cancer Therapy
by: Congyong Sun, et al.
Published: (2025-05-01)

Circular RNAs: key regulators of paclitaxel sensitivity and resistance in cancer
by: Zahra Tajik, et al.
Published: (2025-08-01)

Extended follow-up of the Essential Pro paclitaxel drug-eluting balloon for in-stent restenosis
by: Lucio Padilla, et al.
Published: (2025-05-01)

Nonsteroidal anti-inflammatory drugs in the epoch of biological therapy
by: A E Karateev, et al.
Published: (2008-09-01)

Cyclosporine A Decreased Paclitaxel Resistance in Prostate Cancer Cells by Inhibiting MTDH Expression
by: Jiangtao Li, et al.
Published: (2025-01-01)

Nanogels—Innovative Drug Carriers for Overcoming Biological Membranes
by: Lyubomira Radeva, et al.
Published: (2025-02-01)

Paclitaxel resistance in breast cancer: Current challenges and recent advanced therapeutic strategies
by: Heidi A. Abouzeid, et al.
Published: (2025-01-01)

Design, synthesis, biological assessment, and in silico analysis of bisthiazolidine amide derivatives as potential anti-bacterial and anti-prostate cancer agents
by: Sabah Abbas, et al.
Published: (2025-12-01)

A DFT investigation of the adsorption mechanism of paclitaxel on functionalized graphene oxide for enhanced drug delivery
by: Bader Huwaimel, et al.
Published: (2025-04-01)

Effect of NIMA-related kinase 2B on the sensitivity of breast cancer to paclitaxel in vitro and vivo
by: Yahong Wang, et al.
Published: (2017-04-01)

An Overview of Quinolones as Potential Drugs: Synthesis, Reactivity and Biological Activities
by: Ayoub El-mrabet, et al.
Published: (2025-04-01)

Phototriggerable 2',7-caged paclitaxel.
by: Radu A Gropeanu, et al.
Published: (2012-01-01)

Modern and minimally invasive formulations with paclitaxel
by: Andreea Crețeanu, et al.
Published: (2025-01-01)

Comparison of nab-paclitaxel, paclitaxel, and oxaliplatin-induced peripheral neuropathy: a cross-sectional cohort study
by: Terry Trinh, et al.
Published: (2025-04-01)

Emerging trends and global collaboration in Paclitaxel resistance research for breast cancer: a comprehensive bibliometric study
by: Yuxuan Meng, et al.
Published: (2025-08-01)

Synthesis and biological evaluation of some novel benzoxazin-4-one and quinazolin-4-one derivatives based on anti-inflammatory commercial drugs
by: Shah Alam Khan, et al.
Published: (2024-04-01)

Encapsulation of paclitaxel into date palm lipid droplets for enhanced brain cancer therapy
by: Amal YOUSFAN, et al.
Published: (2024-12-01)

Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction
by: Yimin Lu, et al.
Published: (2017-04-01)

Proinflammatory Factors Mediate Paclitaxel-Induced Impairment of Learning and Memory
by: Zhao Li, et al.
Published: (2018-01-01)

Artificial intelligence and anti-cancer drugs' response
by: Xinrui Long, et al.
Published: (2025-07-01)

Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
by: Peng Cao, et al.
Published: (2023-08-01)

Study on the Synthesis and Biological Activity of Trifluoroacetamide Promoted by Base without Transition-Metal Participation
by: Xing Tian, et al.
Published: (2025-06-01)

Correction: Multifunctional nanobubbles carrying indocyanine green and paclitaxel for molecular imaging and the treatment of prostate cancer
by: Minmin Lan, et al.
Published: (2025-02-01)